Examples of Biologics Act in a sentence
The Biologics Act predates the regulation of drugs under the Pure Food and Drugs Act, which was enacted in 1906.
Prior to the Biologics Act, Congress made several short-lived attempts to regulate specific sectors of the prescription drug market, such as the safety of smallpox vaccine, 2 Stat.
The Biologics Act of 1902 was passed in response to the distribution of tetanus infected diphtheria antitoxin and required licensing of biological drugs sold in interstate commerce.
With the Biologics Act, the brand company controls the challenge process and can decide to assert whichever rights it chooses in whatever order it chooses, potentially across a series of legal battles.102 And of course, those rights are not conveniently listed upfront.In short, brand drugs in the Hatch-Waxman system must put all of their cards on the table; brand drugs in the Biologics system can hide their hands, playing cat-and-mouse games with follow-on drug companies.
In contrast, a biologic follow-on drug maker must meet the higher standards of biosimilarity or interchangeability.The pathway for rapid entry of generics is known as the Hatch- Waxman system;95 the biologic pathway is known by the more complex acronym, BPCIA (the Biologic Price Competition and Innovation Act, hereinafter the “Biologics Act”).96The Biologics Act provides greater protection for branded biologic drugs than Hatch-Waxman provides for branded non- biologic drugs.
Congress created that route to FDA licensure in the Biologics Act in 2010.
Thus, the greater protections available under the Biologics Act further encourage companies to pursue opportunities in the cancer space.
In 1941, three years prior to the re-codification of the Biologics Act, Congress gave the FDA authority over the marketing of insulin.26 Insulin is a peptide hormone, a small protein that regulates carbohydrate metabolism.27 In the 1940s, insulin “was obtained in the same manner as many biologics, namely extraction from animals.
The Biologics Act, however, is even more complex and convoluted than Hatch-Waxman and seems designed on en- tirely the wrong template.329 It took until September 2015—six years after the act’s passage—for the first biosimilar to reach the market.330 Simplification is not the instinct of lawyers in general nor of patent lawyers in particular.
Three years prior to the re-codification of the Biologics Act, Congress gave the FDA authority over the marketing of insulin.21 Insulin is a peptide hormone, a small protein that regulates carbohydrate metabolism.22 In the 1940s, insulin “was obtained in the same manner as many biologics, namely extraction from animals.